Skip to main content

Table 1 Characteristics of subjects enrolled in this study

From: The accumulation of plasma acylcarnitines are associated with poor immune recovery in HIV-infected individuals

Characteristics

Controls

INR

IR

p-value (IR vs INR)

Number of subjects

18

10

10

 

Male (%)

100

100

100

 

Age (years)

37 (35, 38)

33 (29, 49)

39 (30, 43)

 > 0.05

Body mass index (kg/m2)

23 (20.3, 23.0)

21.7 (20.6, 22.8)

21.5 (20.9, 21.9)

 > 0.05

Glucose (mmol/L)

NA

5.3 (4.5, 5.6)

5.0 (4.9, 5.4)

 > 0.05

AST (U/L)

NA

26.5 (23.8, 30.2)

24.6 (23.0, 37.0)

 > 0.05

ALT (U/L)

NA

26.5 (20.3, 35.0)

31.0 (19.0, 50.0)

 > 0.05

Triglyceride (mmol/L)

NA

1.23 (1.00, 1.33)

1.28 (1.09, 1.79)

 > 0.05

Total cholesterol (mmol/L)

NA

3.44 (3.36, 3.90)

4.06 (3.56, 4.28)

 > 0.05

Viral load (copies/mL)

NA

 < 20

 < 20

 

CD4+ T cell count (cells/μL)

    

Baseline

NA

162 (95, 179)

97 (79, 154)

 > 0.05

At 2 years of ART

NA

219 (163, 234)

456 (383, 510)

 < 0.05

Drug regimen

 EFV + 3TC + AZT

NA

2

1

 > 0.05

 EFV + 3TC + TDF

NA

1

1

 NVP + 3TC + AZT

NA

7

8

  1. Data are expressed as the median (interquartile range), unless otherwise stated. NA not available, INR immunological non-responders, IR immunological responders, AST aspartate aminotransferase, ALT alanine aminotransferase